U.S. Accuses Insys Therapeutics Of Paying Kickbacks To Physicians To Prescribe Opioid Spray
The United States intervened in five lawsuits on April 13, 2018 that accuse Insys Therapeutics Inc. (“Insys”) of violating the False Claims Act in connection with the marketing of Subsys, a sublingual spray form of fentanyl (a powerful but highly addictive opioid painkiller), which was a[...]